Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

The controversies of statin therapy: weighing the evidence.

Jukema JW, Cannon CP, de Craen AJ, Westendorp RG, Trompet S.

J Am Coll Cardiol. 2012 Sep 4;60(10):875-81. doi: 10.1016/j.jacc.2012.07.007. Epub 2012 Aug 15. Review.

2.

Risks associated with statin therapy: a systematic overview of randomized clinical trials.

Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM.

Circulation. 2006 Dec 19;114(25):2788-97. Epub 2006 Dec 11. Review.

3.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

4.

Statin diabetogenicity: guidance for clinicians.

Ray K.

Cardiovasc Diabetol. 2013;12 Suppl 1:S3. doi: 10.1186/1475-2840-12-S1-S3. Epub 2013 May 30. Review.

5.

Statin-fibrate combination therapy.

Shek A, Ferrill MJ.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):908-17. Review.

PMID:
11485144
6.

Statin therapy and related risk of new-onset type 2 diabetes mellitus.

Ruscica M, Macchi C, Morlotti B, Sirtori CR, Magni P.

Eur J Intern Med. 2014 Jun;25(5):401-6. doi: 10.1016/j.ejim.2014.03.003. Epub 2014 Mar 27. Review.

PMID:
24685426
7.

[Adverse effects of statins].

Andréjak M, Gras V, Massy ZA, Caron J.

Therapie. 2003 Jan-Feb;58(1):77-83. Review. French.

PMID:
12822204
8.

Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.

Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, Eyawo O, Guyatt G, Berwanger O, Briel M.

QJM. 2011 Feb;104(2):109-24. doi: 10.1093/qjmed/hcq165. Epub 2010 Oct 7. Review.

9.

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

Sattar NA, Ginsberg H, Ray K, Chapman MJ, Arca M, Averna M, Betteridge DJ, Bhatnagar D, Bilianou E, Carmena R, Ceška R, Corsini A, Erbel R, Flynn PD, Garcia-Moll X, Gumprecht J, Ishibashi S, Jambart S, Kastelein JJ, Maher V, da Silva PM, Masana L, Odawara M, Pedersen TR, Rotella CM, Salti I, Teramoto T, Tokgozoglu L, Toth PP, Valensi P, Vergès B.

Atheroscler Suppl. 2014 Jun;15(1):1-15. doi: 10.1016/j.atherosclerosissup.2014.04.001. Review.

PMID:
24840509
10.

Statin use and the risk of incident diabetes mellitus: a review of the literature.

Colbert JD, Stone JA.

Can J Cardiol. 2012 Sep-Oct;28(5):581-9. doi: 10.1016/j.cjca.2012.03.021. Epub 2012 Jun 1. Review.

PMID:
22658337
12.

Statins in clinical medicine.

Rutishauser J.

Swiss Med Wkly. 2011 Nov 21;141:w13310. doi: 10.4414/smw.2011.13310. Review.

13.

Statins and diabetes risk: fact, fiction, and clinical implications.

Rocco MB.

Cleve Clin J Med. 2012 Dec;79(12):883-93. doi: 10.3949/ccjm.79a.12091. Review.

14.

Statin safety: a systematic review.

Law M, Rudnicka AR.

Am J Cardiol. 2006 Apr 17;97(8A):52C-60C. Epub 2006 Feb 3. Review.

PMID:
16581329
16.

Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety.

Kulik A, Ruel M.

Expert Opin Drug Saf. 2009 Sep;8(5):559-71. doi: 10.1517/14740330903188413. Review.

PMID:
19673591
17.

Management of statin-intolerant patient.

Arca M, Pigna G, Favoccia C.

Panminerva Med. 2012 Jun;54(2):105-18. Review.

PMID:
22525565
18.

The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials.

Alsheikh-Ali AA, Karas RH.

Curr Atheroscler Rep. 2009 Mar;11(2):100-4. Review.

PMID:
19228482
19.

Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.

Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH.

J Am Coll Cardiol. 2007 Jul 31;50(5):409-18. Epub 2007 Jul 16. Review.

20.

Safety considerations for statins.

Bolego C, Baetta R, Bellosta S, Corsini A, Paoletti R.

Curr Opin Lipidol. 2002 Dec;13(6):637-44. Review.

PMID:
12441888
Items per page

Supplemental Content

Write to the Help Desk